US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
ヨーロッパ
EU
Sagax Real Estate Socimi SA (MLSAG) 銘柄情報

Sagax Real Estate Socimi SA (MLSAG)

1.14

0.00

(0.00%)

終了 6月7日 12:30AM

Sagax Real Estate Socimi SA (MLSAG) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

1.14

( - )

買値

1.14

売値

1.14

出来高

0.00

0.00 日の範囲 0.00

1.14 52 週間の範囲 1.14

時価総額

前日終値

1.14

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

0.00 €

発行済株式数

325,000,000

配当利回り

PER

19.08

1 株当たり利益 (EPS)

-

歳入

26.16M

純利益

19.42M

Sagax Real Estate SOCIMI, S.A. operates as a real estate investment trust. It engages in the management of logistics and industrial real estate assets located in Spain. The company is based in Barcelona, Spain. Sagax Real Estate SOCIMI, S.A. operates as a real estate investment trust. It engages in the management of logistics and industrial real estate assets located in Spain. The company is based in Barcelona, Spain.

セクター

Real Estate

業界

Reits

ウェブサイト

www.sagax.es

本社

Barcelona, Spain

設立

-

Sagax Real Estate Socimi SA is listed in the Real Estate sector of the ユーロネクスト with ticker MLSAG. The last closing price for Sagax Real Estate Socimi was 1.14 €. Over the last year, Sagax Real Estate Socimi shares have traded in a share price range of 1.14 € to 1.14 €.

Sagax Real Estate Socimi currently has 325,000,000 shares in issue. The market capitalisation of Sagax Real Estate Socimi is 370.50 € million. Sagax Real Estate Socimi has a price to earnings ratio (PE ratio) of 19.08.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	1.14	1.14	1.14	0	0	DE
4	0	0	1.14	1.14	1.14	0	0	DE
12	0	0	1.14	1.14	1.14	0	0	DE
26	0	0	1.14	1.14	1.14	0	0	DE
52	0	0	1.14	1.14	1.14	0	0	DE
156	0	0	1.14	1.14	1.14	0	0	DE
260	0	0	1.14	1.14	1.14	0	0	DE

MLSAG - Frequently Asked Questions (FAQ)

What is the current Sagax Real Estate Socimi SA share price?

The current share price of Sagax Real Estate Socimi SA is 1.14 €

How many Sagax Real Estate Socimi SA shares are in issue?

Sagax Real Estate Socimi SA has 325,000,000 shares in issue

What is the market cap of Sagax Real Estate Socimi SA?

The market capitalisation of Sagax Real Estate Socimi SA is EUR 370.5M

What is the 1 year trading range for Sagax Real Estate Socimi SA share price?

Sagax Real Estate Socimi SA has traded in the range of 1.14 € to 1.14 € during the past year

What is the PE ratio of Sagax Real Estate Socimi SA?

The price to earnings ratio of Sagax Real Estate Socimi SA is 19.08

What is the cash to sales ratio of Sagax Real Estate Socimi SA?

The cash to sales ratio of Sagax Real Estate Socimi SA is 14.16

What is the registered address of Sagax Real Estate Socimi SA?

The registered address for Sagax Real Estate Socimi SA is Calle Maestro Nicolau 19, Barcelona, 08021

What is the Sagax Real Estate Socimi SA website address?

The website address for Sagax Real Estate Socimi SA is www.sagax.es

Which industry sector does Sagax Real Estate Socimi SA operate in?

Sagax Real Estate Socimi SA operates in the REITs sector

Lve

What do you think the price will go to?

joe botts

joe botts 6分前

prowler3701

prowler3701 7分前

Are we still in the quiet period?? LOL!!

Are we still the game changing, jaw dropping, next Lionsgate, tentpole movie, myflix tail that wags the dog, unbelievable movie distributor lol.

17 years of failure buffoon boy CEO.

Jack Wagon CEO!!

richme

Guess there is the problem of numbers in the clientele realm??

flipper44

flipper44 7分前

It’s been half a year since the ASM. It’s been two decades since the phase iii trial appeared on clinicaltrials.gov.

It’s great they are all around the world advocating for cancer vaccines, but we need an update. We need approval.

MHRA/NWBO have taken long enough.

Lve

DewDiligence

DewDiligence 8分前

PFE Berobenatide—dosed monthly—appears to be competitive with Zepbound and Wegovy—dosed weekly—in terms of efficacy and tolerability—see slide 7 at the link in #msg-177679183.

US Market News

US Market News 8分前

Lilly's triple agonist, retatrutide, drove substantial improvements in weight, A1C, knee osteoarthritis pain, and obstructive sleep apnea, demonstrating its remarkable potential to treat obesity and its complicationsJune 6, 2026 2:30 PM
PR Newswire (US)

DewDiligence

DewDiligence 9分前

Berobenatide—dosed monthly—appears_ competitive_with_weekly Zepbound and Wegovy in_terms_of efficacy and tolerability—see slide 7 at the link in #msg-177679183.

janice shell

janice shell 9分前

It’s about time!!

GeorgSchreiberEU

GeorgSchreiberEU 12分前

Interesting development:

MSN has updated the name (not the ticker symbol) ... while OTC website still shows Natama

https://www.msn.com/en-us/money/stockdetails/fi-b19gfr?ocid=msedgntp&id=b19gfr

Rattlershehe

Rattlershehe 14分前

Well, 55 his to skinny. Sigma pharmaceuticals was not in our wheelhouse. As an advisor to the company, the easiest way that I could say is. The whole Sigma thing went south as soon as the books needed to be audited. They did not want anyone in their business.
Methylene blue came into the pic

brazen22

brazen22 15分前

The “as quickly as possible” versus “as many as possible” framing has a problem.

If someone had GBM 2.5 years ago, I doubt they would view delay as acceptable because it might help reach more patients later. For the current GBM population, the fastest path matters.

Appr

mascale

mascale 16分前

Qatar (royals) famous for recent lawful outcomes.

TightCoil

TightCoil 16分前

Pulte Related? or Not?
IC3: Industry Alerts
Safeguarding Our Secrets
https://www.ic3.gov/CSA/2026/260603.pdf
June 3, 2026
Full Press Release

________________________________________

Ssgiants89

Ssgiants89 19分前

Did anyone else catch the NBA championship game? I saw Jalen Brunson was wearing some type of venom gear to help with pain. I looked it up. It looks like it operates with heat and vibration. We need to send this man and actipatch!!

chumfm

chumfm 20分前

They are issuing millions of shares to cover their ATM.You will see upon completion a RS to move the price back to compliance.Check out CHR,same buyout,non-binding,and they formed a committee to look at the offer.Still no response and they already did a RS,after issuing millions of more shares.They

iateclube

iateclube 21分前

"The name and the material are called Liquidmetal' .... which Apple may or may not ever use. I agree with you though, they would probably want to use it even though Apple is funny about any outside name association. At the same time, liquidmetal is recognized as a generic substance. I suppose t

IhidfromtheX

IhidfromtheX 21分前

Well then in that case, we "should" be seeing revenue's! Are the sales going good in Europe?

peafunke

peafunke 21分前

https://dataintelo.com/report/concert-live-streaming-market
Always thought that was a bit high. Nevertheless sure. But that’s not how you debut an app and grow / retain users. Eventually it will be a piece of the pie.
Less go

Timing101

Timing101 23分前

$SRXH I have posted in some time, but holding strong and added this past week again . all good here. The DD is strong , not going by all the IMO (in my opinion) folks out there, just the facts, disclosures and potential.

trusttheman

trusttheman 23分前

Go Knicks and go Tptw!!!!! Suck it doubters!!!!

1manband

1manband 23分前

"We are tired of this nonsense"

There Are Millions of Crypto Tokens. Almost None Have Any Value

https://finance.yahoo.com/markets/crypto/articles/millions-crypto-tokens-almost-none-150000991.html

Charles Hoskinson is angry.

The founder of C

my3sons87

my3sons87 23分前

There are a few reasons why Simply Wall St articles about a company such as InterDigital can appear disproportionately negative, even when the underlying platform is not intentionally bearish.

My assessment is that the apparent negativity is more likely a consequence of rule-based and

magikalalpha

magikalalpha 25分前

https://x.com/DeborahHat96840/status/2063322755949273163?s=20

Sagax Real Estate Socimi

Wt 5x S Eur L�

Ing Emrg Europe Fd

Cardiff Auto Receivables...

Activepassive Internatio...

Booz Allen Hamilton

Miramar Resources

Euronext Eurozone Small ...

Panorama Auto Trust 2024 3

Leading Edge Materials

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。